Method for treatment and control of plant disease
AssigneeThe Texas A&MUniversity System
InventorsCarlos F. Gonzalez, Stephen J. Ahern, Mayukh Das, Ryland F. Young, III, Tushar Suvra Bhowmick
Life of this patent
Estimating the term…
Abstract
Methods and compositions are provided for preventing or reducing symptoms or disease associated with Xylella fastidiosa or Xanthomonas axonopodis in a plant. The invention provides novel bacteriophages virulent to Xylella fastidiosa or Xanthomonas axonopodis, including XfaMija and XfaMijo, and further provides methods for treating or preventing Pierce's Disease or Citrus Canker in plants.
Claims10
A method of preventing or reducing symptoms or disease associated with Xylella fastidiosa or Xanthomonas in a plant, comprising contacting said plant with particles of at least one virulent bacteriophage for Xylella fastidiosa and/or Xanthomonas, wherein the virulent bacteriophage is selected from the group consisting of the Xfas100 phage type, the Xfas300 phage type and Xfas500 phage type;
- wherein the Xfas100 phage type has the following characteristics:
- (a) the bacteriophage is capable of lysing said Xylella fastidiosa and/or Xanthomonas bacteria;
- (b) the bacteriophage infects a cell by binding to a Type IV pilus;
- (c) the bacteriophage comprises a non-contractile tail and a capsid size ranging from 55-77 nm in diameter, with a morphology typical of Siphoviridae family;
- and
- (d) the genomic size of the bacteriophage is about 55,500 bp to 56,200 bp;
- the Xfas300 phage type has the following characteristics:
- (e) the bacteriophage is capable of lysing said Xylella fastidiosa and/or Xanthomonas bacteria;
- (f) the bacteriophage infects a cell by binding to a Type IV pilus;
- (g) the bacteriophage comprises a morphology typical of Podoviridae family characterized by a non-contractile tail with a capsid size ranging from 58-68 nm in diameter;
- and
- (h) the genomic size of the bacteriophage is about 43,300 bp to 44,600 bp;
- or the Xfas500 phage type has the following characteristics:
- (i) the bacteriophage is capable of lysing said Xylella fastidiosa and/or Xanthomonas bacteria;
- (j) the bacteriophage infects a cell by adsorption to a Type IV pilus;
- (k) the bacteriophage comprises a contractile tail with a capsid size ranging from 85 nm-95 nm in diameter;
- and
- l) the genomic size of the bacteriophage is about 190,000 bp to 230,000 bp.
Dependencies are inferred from the claim text.